Viewing Study NCT05509894


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-02-09 @ 6:45 AM
Study NCT ID: NCT05509894
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2022-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pediatric Growth Hormone Deficiency View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pediatric Growth Hormone Deficiency View
None Somatrogon View